Extracellular adenosine induces apoptosis of human arterial smooth muscle cells via A(2b)-purinoceptor

Circulation Research

Volumn 86, Issue 1, 2000, Pages 76-85

  Peyot, Marie Line ^a   Gadeau, Alain Pierre ^a   Dandré, Frédéric ^a   Belloc, Isabelle ^a   Dupuch, Françoise ^a   Desgranges, Claude ^a  

^a INSERM   (France)

Author keywords

A(2b) purinoceptor; Adenosine; Apoptosis; Arterial smooth muscle cell; CAMP

Indexed keywords

8 [4 (2 AMINOETHYLCARBAMOYL)METHOXYPHENYL] 1,3 DIPROPYLXANTHINE; ADENOSINE; ADENOSINE A1 RECEPTOR ANTAGONIST; ADENOSINE A2 RECEPTOR ANTAGONIST; ADENOSINE A2B RECEPTOR; CYCLIC AMP DEPENDENT PROTEIN KINASE;

APOPTOSIS; ARTERY INTIMA PROLIFERATION; ARTERY MUSCLE; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REGULATORY MECHANISM; RESTENOSIS;

EID: 0033959242     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.86.1.76     Document Type: Article

References (64)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809.
2. Jackson CL, Schwartz SM. Pharmacology of smooth muscle cell replication. Hypertension. 1992;20:713-736.
3. Casscells W. Migration of smooth muscle and endothelial cells: critical events in restenosis. Circulation. 1992;86:723-729.
4. O'Brien ER, Alpers CE, Stewart DK, Ferguson M, Tran N, Gordon D, Benditt EP, Hinohara T, Simpson JB, Schwartz SM. Proliferation in primary and restenotic coronary atherectomy tissues: implications for antiproliferative therapy. Circ Res. 1993;73:223-231.
5. Han DKM, Haudenschild CC, Hong MK, Tinkle BT, Leon MB, Liau G. Evidence for apoptosis in human atherogenesis and in a rat vascular injury model. Am J Pathol. 1995;147:267-271.
6. Guyton JR, Black BL, Seidel CL. Focal toxicity of oxysterols in vascular smooth muscle cell culture: a model of the atherosclerotic core region. Am J Pathol. 1990;137:425-434.
7. Geng YJ, Libby P. Evidence for apoptosis in advanced human atheroma: colocalization with interleukin-1β-converting enzyme. Am J Pathol. 1995;147:251-266.
8. Isner JM, Kearney M, Bortman S, Passeri J. Apoptosis in human atherosclerosis and restenosis. Circulation. 1995;91:2703-2711.
9. Björkerud S, Björkerud B. Apoptosis is abundant in human atherosclerotic lesions, especially in inflammatory cells (macrophages and T cells), and may contribute to the accumulation of gruel and plaque instability. Am J Pathol. 1996;149:367-380.
10. Crisby M, Kallin B, Thyberg J, Zhivotovsky B, Orrenius S, Kostulas V, Nilsson J. Cell death in human atherosclerotic plaques involves both oncosis and apoptosis. Atherosclerosis. 1997;130:17-27.
11. Bombeli T, Karsan A, Tait JF, Harlan JM. Apoptotic vascular endothelial cells become procoagulant. Blood. 1997;89:2429-2442.
12. Majno G, Joris I. Apoptosis, oncosis and necrosis: an overview of cell death. Am J Pathol. 1995;146:3-15.
13. Vaux DL, Strasser A. The molecular biology of apoptosis. Proc Natl Acad Sci U S A. 1996;93:2239-2244.
14. Bochaton-Piallat ML, Gabbiani F, Redard M, Desmoulière A, Gabbiani G. Apoptosis participates in cellularity regulation during rat aortic intimal thickening. Am J Pathol. 1995;146:1059-1064.
15. Lopez-Candales A, Holmes DR, Scott MJ, Thompson RW, Wickline SA. Effects of ultraviolet light in vascular cells in vitro and in intact atherosclerotic explants: potential role of apoptosis in vascular biology. Biochem Cell Biol. 1996;74:333-345.
16. Pollman MJ, Yamada T, Horiuchi M, Gibbons GH. Vasoactive substances regulate vascular smooth muscle cell apoptosis: countervailing influences of nitric oxide and angiotensin II. Circ Res. 1996;79: 748-756.
17. Nishio E, Arimura S, Watanabe Y. Oxidized LDL induces apoptosis in cultured smooth muscle cells: a possible role for 7-ketocholesterol. Biochem Biophys Res Commun. 1996;223:413-418.
18. Li PF, Dietz R, Von Harsdorf R. Reactive oxygen species induce apoptosis of vascular smooth muscle cell. FEBS Lett. 1997;404: 249-252.
19. Geng YJ, Wu Q, Muszynski M, Hansson GK, Libby P. Apoptosis of vascular smooth muscle cells by in vitro stimulation with interferon-γ, tumor necrosis factor-α, and interleukin-1β. Arterioscler Thromb Vase Biol. 1996;16:19-27.
20. Leszczynski D, Zhao Y, Luokkamäki M, Foegh ML. Apoptosis of vascular smooth muscle cells: protein kinase C and oncoprotein Bcl-2 are involved in regulation of apoptosis in nontransformed rat vascular smooth muscle cells. Am J Pathol. 1994;145:1265-1270.
21. Kizaki H, Suzuki K, Ishimura Y. Adenosine receptor-mediated accumulation of cyclic AMP-induced T-lymphocyte death through internucleosomal DNA cleavage. J Biol Chem. 1990;265:5280-5284.
22. 2+-mediated mechanisms. Biochem J. 1994;304: 877-885.
23. Tanaka Y, Yoshihara K, Tsuyuki M, Kamiya T. Apoptosis induced by adenosine in human leukemia HL-60. Exp Cell Res. 1994;213: 242-252.
24. Kohno Y, Sei Y, Koshiba M, Kim HO, Jacobson KA. Induction of apoptosis in HL-60 human promyelocytic leukemia cells by adenosine A3 receptor agonists. Biochem Biophys Res Commun. 1996;219: 904-910.
25. Dubey RK, Mi Z, Gillespie DG, Jackson EK. Cyclic AMP-adenosine pathway inhibits vascular smooth muscle cell growth. Hypertension. 1996;28:765-771.
26. Palmer TM, Stiles GL. Adenosine receptors. Neuropharmacology. 1995;34:683-694.
27. Dixon AK, Gubitz AK, Sirinathsinghji DJS, Richardson PJ, Freeman TC. Tissue distribution of adenosine receptor mRNAs in the rat. Br J Pharmacol. 1996;118:1461-1468.
28. Salvatore CA, Jacobson MA, Taylor HE, Linden J, Johnson RG. Molecular cloning and characterization of the human A3 adenosine receptor. Proc Natl Acad Sci U S A. 1993;90:10365-10369.
29. Thyberg J, Palmberg L, Nilsson J, Ksiazek T, Sjökund M. Phenotype modulation in primary cultures of arterial smooth muscle cells: on the role of platelet-derived growth factor. Differentiation. 1983;25: 156-167.
30. Kitsis RN, Liu Y. Induction of DNA synthesis and apoptosis in cardiac myocytes by E1A protein. J Cell Biol. 1996;133:325-334.
31. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-254.
32. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680-685.
33. Puffinbarger NK, Hansen KR, Resta R, Laurent AB, Knudsen TB, Madara JL, Thompson LF. Production and characterization of multiple antigenic peptide antibodies to the adenosine A2b receptor. Mol Pharmacol. 1995;47:1126-1132.
34. Pierce KD, Furlong TJ, Selbie LA, Shine J. Molecular cloning and expression of an adenosine A2b receptor from human brain. Biochem Biophys Res Commun. 1992;187:86-93.
35. Fredholm, BB, Abbracchio MP, Burnstock G, Daly JW, Kendall Harden T, Jacobson KA, Leff P, Williams M. Nomenclature and classification of purinoceptors. Pharmacol Rev. 1994;46:143-156.
36. Klotz KN, Hessling J, Hegler J, Owman C, Kull B, Fredholm BB, Lohse MJ. Comparative pharmacology of human adenosine receptor subtypes: characterization of stably transfected receptors in CHO cells. Naunyn-Schmiedebergs Arch Pharmacol. 1998;357:1-9.
37. Robeva AS, Woodhard RL, Jin X, Gao Z, Bhattacharya S, Taylor HE, Rosin DL, Linden J. Molecular characterization of recombinant human adenosine receptors. Drug Dev Res. 1996;39:243-252.
38. de Souza NJ, Dohadwalla AN, Reden J. Forskolin: a labdane diterpenoid with antihypertensive, positive inotropic, platelet aggregation inhibitory, and adenylate cyclase activating properties. Med Res Rev. 1983;3:201-219.
39. Reeves ML, Leigh BK, England PJ. The identification of a new cyclic nucleotide phosphodiesterase activity in human and guinea-pig cardiac ventricle: implications for the mechanism of action of selective phosphodiesterase inhibitors. Biochem J. 1987;241:535-541.
40. Goldsmith BA, Abrams TW. Reversal of synaptic depression by serotonin at Aplysia sensory neuron synapses involves activation of adenylyl cyclase. Proc Natl Acad Sci U S A. 1991;88:9021-9025.
41. Chen HC, Kemp BE, Pearson RB, Smith AJ, Misconi L, Van Patten SM, Natsh DA. A potent synthetic peptide inhibitor of the cAMP-dependent protein kinase. J Biol Chem. 1986;261:989-992.
42. Bruns RF, Lu GH, Pugsley TA. Characterization of the A2 adenosine receptor labeled by [3H]NECA in rat striatal membranes. Mol Pharmacol. 1986;29:331-346.
43. Brackett LE, Daly JW. Functional characterization of the A2b adenosine receptor in NIH 3T3 fibroblasts. Biochem Pharmacol. 1994;47: 801-814.
44. Strohmeier GR, Reppert SM, Lencer WI, Madara JL. The A2b adenosine receptor mediates cAMP responses to adenosine receptor agonists in human intestinal epithelia. J Biol Chem. 1995;270: 2387-2394.
45. Dubey RK, Gillespie DG, Mi Z, Suzuki F, Jackson EK. Smooth muscle cell-derived adenosine inhibits cell growth. Hypertension. 1996;27:766-773.
46. Dubey RK, Gillespie DG, Osaka K, Suzuki F, Jackson EK. Adenosine inhibits growth of rat aortic smooth muscle cells: possible role of A2b receptor. Hypertension. 1996;27:786-793.
47. Takiguchi Y, Nagano M, Ikeda Y, Nakashima M. Early administration of YT-146, an adenosine A2 receptor agonist, inhibits neointimal thickening after rat femoral artery endothelium injury. Eur J Pharmacol. 1995;281:205-207.
48. Seo HG, Fujii J, Asahi M, Fujiwara N, Taniguchi N. Roles of purine nucleotides and adenosine in enhancing NOS II gene expression in interleukin-1β-stimulated rat vascular smooth muscle cells. Free Radic Res. 1997;26:409-418.
49. Dubey RK, Gillespie DG, Jackson EK. Cyclic AMP-adenosine pathway induces nitric oxide synthesis in aortic smooth muscle cells. Hypertension. 1998;31:296-302.
50. Garg UC, Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest. 1989;83:1774-1777.
51. MacLean DA, Sinoway LI, Leuenberger U. Systemic hypoxia elevates skeletal muscle interstitial adenosine levels in humans. Circulation. 1998;98:1990-1992.
52. Mei DA., Gross GJ, Nithipatikom K. Simultaneous determination of adenosine, inosine, hypoxanthine, xanthine, and uric acid in microdialysis samples using microbore column high-performance liquid chromatography with a diode array detector. Anal Biochem. 1996;238:34-39.
53. Lasley RD, Konyn PJ, Hegge JO, Mentzer RM. Effects of ischemic and adenosine preconditioning on interstitial fluid adenosine and myocardial infarct size. Am J Physiol. 1995;269:H1460-H1466.
54. Van Wylen DG, Willis J, Sodhi J, Weiss RJ, Lasley RD, Mentzer RM. Cardiac microdialysis to estimate interstitial adenosine and coronary blood flow. Am J Physiol. 1990;258:H1642-H1649.
55. Domenech RJ, Macho P, Vélez D, Sánchez G, Liu X, Dhalla N. Tachycardia preconditions infarct size in dogs: role of adenosine and protein kinase C. Circulation. 1998;97:786-794.
56. Smolenski RT, Kochan Z, McDouall R, Page C, Seymour AL, Yacoub MH. Endothelial nucleotide catabolism and adenosine production. Cardiovasc Res. 1994;28:100-104.
57. Gordon EL, Pearson JD, Dickinson ES, Moreau D, Slakey LL. The hydrolysis of extracellular adenine nucleotides by arterial smooth muscle cells. J Biol Chem. 1989;32:18986-18992.
58. Beigi R, Kobatake E, Aizawa M, Dubyak GR. Detection of local ATP release from activated platelets using cell surface-attached firefly luciferase. Am J Physiol. 1999;276:C267-C278.
59. Devidas S, Guggino WB. The cystic fibrosis transmembrane conductance regulator and ATP. Curr Opin Cell Biol. 1997;9:547-552.
60. Ethier MF, Dobson JG. Adenosine stimulation of DNA synthesis in human endothelial cells. Am J Physiol. 1997;272:H1470-H1479.
61. Albina JE, Cui S, Mateo RB, Reichner JS. Nitric oxide-mediated apoptosis in murine peritoneal macrophages. J Immunol. 1993;150: 5080-5085.
62. Sarih M, Souvannavong V, Adam A. Nitric oxide synthase induces macrophage death by apoptosis. Biochem Biophys Res Commun. 1993; 191:503-508.
63. Hori M, Kitakaze M. Adenosine, the heart, and coronary circulation. Hypertension. 1991;18:565-574.
64. Olsson RA, Pearson JD. Cardiovascular purinoceptors. Physiol Rev. 1990;70:761-845.